Medaffcon-news

Prototype of a Gaucher disease point-scoring system successfully tested in Finnish patients
15.03.2021
New RWE themed blog to start in March!
23.02.2021
Finnish ecosystem supports the use of real world evidence (RWE)
17.12.2020
Market access, pricing and reimbursement of medicines in Finland
17.11.2020
My Migraine Voice -survey reveals the emotional and social burden of migraine in Finland
12.10.2020
Navigating the RWD landscape in Finland
29.09.2020
Specific patient characteristics of heart failure across the LVEF range highlight the importance of effective treatments to reduce hospitalizations
17.09.2020
Multimorbidity across multiple ICD-10 codes should be considered when treating migraine patients
05.03.2020
The Burden of Idiopathic Pulmonary Fibrosis (IPF) in Finland
20.02.2020
The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland
13.11.2019
Machine learning based tools in the analysis of RWD; focus on image recognition
22.10.2019
Migraine comorbidity and phenotypic disease networks in occupational health care
10.09.2019
The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization
21.08.2019
HIMSS & Health 2.0 European Conference
25.06.2019
Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use
23.05.2019
Migraine nearly doubles the amount of healthcare visits and sick-leave days
14.03.2019
Finnish pricing and reimbursement landscape
25.02.2019
Medaffcon’s article in the latest biobanking magazine
09.01.2019
BC Platforms and Medaffcon Join Forces to Streamline Collaboration Between Biobanks and Researchers
11.12.2018
A survey conducted by Medaffcon Oy and the University of Eastern Finland reviewed the operational status of Finnish hospital biobanks.
23.10.2018
Managed entry agreements facilitate the access of new medicines
12.10.2018
AI-based tools for mining electronic health record data
24.09.2018
Finnish hospital biobanks promote research both nationally and internationally
25.06.2018
Real world evidence (RWE) supported health technology assessment (HTA)
07.06.2018
Unique platform promotes efforts to advance customized cancer care
12.04.2018
Possibilities of machine learning and artificial intelligence in RWE studies
08.04.2018
Risk-Sharing Agreements
06.04.2018
Conditional reimbursement facilitates the introduction of new treatments
05.04.2018
Unique mapping on personalised cancer care
26.01.2018
Medaffcon’s new cooperation project aims at better utilisation of biobank health data
08.01.2018